ASCIA Immunodeficiency Strategy | ASCIA TAPID Project | APID Training Meetings | ASCIA Immunodeficiency Register

ASCIA has significantly expanded its range of information for health professionals and patients on Primary Immunodeficiency (PID) since 2013, including the ASCIA Transplantation and PID (TAPID) Project, development of  the ASCIA  Immunodeficiency Strategy, ASCIA PID e-training, APID training meetings, the ASCIA Immunodeficiency Diseases Register, resources to support the use of subcutaneous and intravenous immunoglobulin (SCIg/IVIg) and a dedicated webpage to access the reosurces.

ASCIA Immunodeficiency Strategy 

On 8th March 2019 ASCIA hosted a meeting in Melbourne to develop the ASCIA Immunodeficiency Strategy for Australia and New Zealand. The mission is to improve the health and wellbeing of people with primary immunodeficiencies (PIDs) and minimise the impact on individuals, carers, health services and the community.

Further information:

ASCIA TAPID Collaboration

TAPID (Transplantation and PID) is an important collaboration facilitated by ASCIA, between clinical immunologists, transplant physicians and international PID experts.  For more details go to

ASCIA PID (APID) Training Meetings

The most recent ASCIA Primary Immunodeficiency (APID) Training Meeting was held from Sunday 26 May to Thursday 30 May 2019. Further information

ASCIA Immunodeficiency (ID) Register

The ASCIA Immunodeficiency Disease Register is available at 

The aim of this Register is to collect and analyse de-identified data from all participating centres around Australasia. Analysis of the collected data will be able to inform current and future practice. Any future publications of data will acknowledge (with consent) anyone who has entered their patient data. Use of the Immunodeficiency Disease Register requires a username and password.

Content Updated October 2020

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia